Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Chromosomal Numerical Aberrations and Rare Copy Number Variation in Patients with Inflammatory Bowel Disease

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and Aims

          Inflammatory bowel diseases [IBD] have a complex polygenic aetiology. Rare genetic variants can cause monogenic intestinal inflammation. The impact of chromosomal aberrations and large structural abnormalities on IBD susceptibility is not clear. We aimed to comprehensively characterise the phenotype and prevalence of patients with IBD who possess rare numerical and structural chromosomal abnormalities.

          Methods

          We performed a systematic literature search of databases PubMed and Embase; and analysed gnomAD, Clinvar, the 100 000 Genomes Project, and DECIPHER databases. Further, we analysed international paediatric IBD cohorts to investigate the role of IL2RA duplications in IBD susceptibility.

          Results

          A meta-analysis suggests that monosomy X [Turner syndrome] is associated with increased expressivity of IBD that exceeds the population baseline (1.86%, 95% confidence interval [CI] 1.48 to 2.34%) and causes a younger age of IBD onset. There is little evidence that Klinefelter syndrome, Trisomy 21, Trisomy 18, mosaic Trisomy 9 and 16, or partial trisomies contribute to IBD susceptibility. Copy number analysis studies suggest inconsistent results. Monoallelic loss of X-linked or haploinsufficient genes is associated with IBD by hemizygous or heterozygous deletions, respectively. However, haploinsufficient gene deletions are detected in healthy reference populations, suggesting that the expressivity of IBD might be overestimated. One duplication that has previously been identified as potentially contributing to IBD risk involves the IL2RA/IL15R loci. Here we provide additional evidence that a microduplication of this locus may predispose to very-early-onset IBD by identifying a second case in a distinct kindred. However, the penetrance of intestinal inflammation in this genetic aberration is low [<2.6%].

          Conclusions

          Turner syndrome is associated with increased susceptibility to intestinal inflammation. Duplication of the IL2RA/IL15R loci may contribute to disease risk.

          Graphical Abstract

          Related collections

          Most cited references58

          • Record: found
          • Abstract: found
          • Article: not found

          Proteomics. Tissue-based map of the human proteome.

          Resolving the molecular details of proteome variation in the different tissues and organs of the human body will greatly increase our knowledge of human biology and disease. Here, we present a map of the human tissue proteome based on an integrated omics approach that involves quantitative transcriptomics at the tissue and organ level, combined with tissue microarray-based immunohistochemistry, to achieve spatial localization of proteins down to the single-cell level. Our tissue-based analysis detected more than 90% of the putative protein-coding genes. We used this approach to explore the human secretome, the membrane proteome, the druggable proteome, the cancer proteome, and the metabolic functions in 32 different tissues and organs. All the data are integrated in an interactive Web-based database that allows exploration of individual proteins, as well as navigation of global expression patterns, in all major tissues and organs in the human body. Copyright © 2015, American Association for the Advancement of Science.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The mutational constraint spectrum quantified from variation in 141,456 humans

            Genetic variants that inactivate protein-coding genes are a powerful source of information about the phenotypic consequences of gene disruption: genes that are crucial for the function of an organism will be depleted of such variants in natural populations, whereas non-essential genes will tolerate their accumulation. However, predicted loss-of-function variants are enriched for annotation errors, and tend to be found at extremely low frequencies, so their analysis requires careful variant annotation and very large sample sizes 1 . Here we describe the aggregation of 125,748 exomes and 15,708 genomes from human sequencing studies into the Genome Aggregation Database (gnomAD). We identify 443,769 high-confidence predicted loss-of-function variants in this cohort after filtering for artefacts caused by sequencing and annotation errors. Using an improved model of human mutation rates, we classify human protein-coding genes along a spectrum that represents tolerance to inactivation, validate this classification using data from model organisms and engineered human cells, and show that it can be used to improve the power of gene discovery for both common and rare diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease

              Genetic association studies have identified 215 risk loci for inflammatory bowel disease 1–8, which have revealed fundamental aspects of its molecular biology. We performed a genome-wide association study of 25,305 individuals, and meta-analyzed with published summary statistics, yielding a total sample size of 59,957 subjects. We identified 25 new loci, three of which contain integrin genes that encode proteins in pathways identified as important therapeutic targets in inflammatory bowel disease. The associated variants are correlated with expression changes in response to immune stimulus at two of these genes (ITGA4, ITGB8) and at previously implicated loci (ITGAL, ICAM1). In all four cases, the expression increasing allele also increases disease risk. We also identified likely causal missense variants in the primary immune deficiency gene PLCG2 and a negative regulator of inflammation, SLAMF8. Our results demonstrate that new common variant associations continue to identify genes relevant to therapeutic target identification and prioritization.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Crohns Colitis
                J Crohns Colitis
                eccojc
                Journal of Crohn's & Colitis
                Oxford University Press (UK )
                1873-9946
                1876-4479
                January 2023
                30 July 2022
                30 July 2022
                : 17
                : 1
                : 49-60
                Affiliations
                Translational Gastroenterology Unit and Biomedical Research Centre, Nuffield Department of Clinical Medicine, University of Oxford , Oxford, UK
                Department of Pediatrics, UT Southwestern Medical Center , Dallas TX, USA
                Institute of Child Health, University College London , London, UK
                Paediatric Gastroenterology Department, Great Ormond Street Hospital for Children NHS Foundation Trust , London, UK
                SickKids Inflammatory Bowel Disease Centre, Hospital for Sick Children , Toronto, ON, Canada
                Paediatric Gastroenterology Department, Great Ormond Street Hospital for Children NHS Foundation Trust , London, UK
                Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford , Oxford, UK
                Primary Immunodeficiency Group, Newcastle University Translational and Clinical Research Institute , Newcastle upon Tyne, UK
                Genomics England , London, UK
                Department of Pathology and the Eugene McDermott Center for Human Growth and Development. UT Southwestern Medical Center , Dallas, TX, USA
                German Clinic for Diagnostics [DKD], Helios Klinik , Wiesbaden, Germany
                Laboratory of Immunology and Cellular Therapy, Great Ormond Street Hospital for Children, NHS Foundation Trust , London, UK
                Primary Immunodeficiency Group, Newcastle University Translational and Clinical Research Institute , Newcastle upon Tyne, UK
                SickKids Inflammatory Bowel Disease Centre, Hospital for Sick Children , Toronto, ON, Canada
                Department of Biochemistry, University of Toronto , Toronto, ON, Canada
                Cell Biology Program, Sick Kids Research Institute, Hospital for Sick Children , Toronto, ON, Canada
                Department of Pediatrics, University of Toronto , Toronto, ON, Canada
                Institute of Medical Science, University of Toronto , Toronto, ON, Canada
                Department of Pediatrics, and Department of Internal Medicine, University of Texas Southwestern Medical Center , Dallas, TX, USA
                Translational Gastroenterology Unit and Biomedical Research Centre, Nuffield Department of Clinical Medicine, University of Oxford , Oxford, UK
                Biomedical Research Centre, University of Oxford , Oxford, UK
                Department of Paediatrics, John Radcliffe Hospital , Oxford, UK
                Author notes
                Corresponding author: Holm H. Uhlig, Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK. Tel.: 0044 1865 8 57963; Email: holm.uhlig@ 123456ndm.ox.ac.uk
                Author information
                https://orcid.org/0000-0003-0240-3244
                https://orcid.org/0000-0001-6797-4000
                https://orcid.org/0000-0001-9624-3346
                Article
                jjac103
                10.1093/ecco-jcc/jjac103
                9880952
                35907265
                5ffee228-687e-4d3b-ad42-e44693c7ea3d
                © The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 16 August 2022
                Page count
                Pages: 12
                Funding
                Funded by: National Institute for Health Research, DOI 10.13039/501100000272;
                Funded by: Oxford Biomedical Research Centre;
                Funded by: Leona M. and Harry B. Helmsley Charitable Trust, DOI 10.13039/100007028;
                Funded by: UK Medical Research Council, DOI 10.13039/501100000265;
                Award ID: MR/R008019/1
                Funded by: Canadian Institutes of Health Research, DOI 10.13039/501100000024;
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases, DOI 10.13039/100000062;
                Funded by: National Institutes of Health, DOI 10.13039/100000002;
                Award ID: RC2DK118640
                Award ID: RC2DK122532
                Funded by: National Institute for Health Research, DOI 10.13039/501100000272;
                Funded by: National Health Service England;
                Funded by: Wellcome Trust, DOI 10.13039/100010269;
                Funded by: Cancer Research UK, DOI 10.13039/501100000289;
                Funded by: Medical Research Council, DOI 10.13039/501100000265;
                Categories
                Original Articles
                AcademicSubjects/MED00260
                Eccojc/1100

                Comments

                Comment on this article